An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases

Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic asthma. Omalizumab is the unique biologic treatment registered for asthma therapy in children. The clinical efficacy and safety of omalizumab treatment in the pediatric population has been extensively...

Descripción completa

Detalles Bibliográficos
Autores principales: Licari, Amelia, Castagnoli, Riccardo, Panfili, Elisa, Marseglia, Alessia, Brambilla, Ilaria, Marseglia, Gian Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735517/
https://www.ncbi.nlm.nih.gov/pubmed/29290750
http://dx.doi.org/10.2174/1573398X13666170616110738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735517/
https://www.ncbi.nlm.nih.gov/pubmed/29290750
http://dx.doi.org/10.2174/1573398X13666170616110738

Ejemplares similares